What does Bionano genomics company do?

Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.

Table of Contents

Where is Bionano genomics located?

BioNano Genomics headquarters is located at 9640 Towne Centre Dr #100, San Diego.

Is BNGO a good investment?

The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.

What kind of company is Bionano Genomics Inc?

life sciences instrumentation company
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.

Is BNGO a pump and dump?

BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.

Who are Bionano genomics competitors?

BioNano Genomics’s competitors are BioDiscovery, Fluxion Biosciences, IRX Therapeutics, Hepregen, Genvault Corporation and more.

Is BNGO expected to rise?

Bionano Genomics Inc (NASDAQ:BNGO) The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +351.81% increase from the last price of 1.66.

Will Bionano Genomics stock go up?

Does BNGO have potential?

Moving forward, BNGO has a promising potential with solid synergy from its previous acquisition of BioDiscovery and the integration of OGM and NGS technologies.

How many employees does Bionano genomics?

147 total
Bionano Genomics, Inc. has 147 total employees across all of its locations and generates $17.98 million in sales (USD). There are 8 companies in the Bionano Genomics, Inc….Just $139.99 *

Year	Operating Income
2018	-20.42
2019	-25.87
2020	-38.55

Who is buying BNGO?

Institutional investors purchased a net $3.1 million shares of BNGO during the quarter ended March 2019….Top 10 Owners of Bionano Genomics Inc.

Stockholder	BlackRock Fund Advisors
Shares owned	16,609,007
Total value ($)	35,543,275
Shares bought / sold	+407,569
Total change	+2.52%

What company makes the genome sequencer?

Early this year, Illumina, the manufacturer of most of the world’s DNA sequencers, unveiled its newest, most efficient machine, NovaSeq, which can sequence as many as 48 entire human genomes in two and a half days, according to the company.

What is BioNano genomics?

Bionano Genomics provides unparalleled structural variation detection for genetic disease research, cancer research & cytogenomics with genome imaging technology. Bionano Genomics provides unparalleled structural variation detection for genetic disease research, cancer research & cytogenomics with genome imaging technology.

Is registration open for the BioNano genomics 2022 Symposium?

Registration is now open for the Bionano Genomics 2022 Symposium! Symposium will feature four consecutive days of OGM presentations delivered by 25 different customers worldwide across a wide range of genetic diseases and cancer applications. Join us virtually January 10-13, 2022.

What is genome assembly with BioNano Saphyr?

Bionano Saphyr’s industry-leading genome assembly capabilities allow you to align sequencing data with Bionano genome maps to view genomes with all features and functional relationships in context.

Why choose BioNano?

At Bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality of life for all.